SFX by Ex Libris Inc.

Title:	Molecular Engineering of Viral Gene Delivery Vehicles
Source:	Annual Review of Biomedical Engineering [1523-9829] Schaffer, David yr:2008

Basic

Full text

Full text available via Annual Reviews

Year:

Volume:

Issue:

Start Page:

Full text available via Annual Reviews Back Volume Collection

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Kwon, I. "Designer gene delivery vectors: Molecular engineering and evolution of adeno-associated viral vectors for enhanced gene transfer." Pharmaceutical Research 25.3 (2008): 489-499.
description	2.	Nardi, Nance Beyer B. "The state of the art of adeno-associated virus-based vectors in gene therapy." Virology journal 4.1 (2007): 99-99.
description	3.	Edelstein, Michael L L. "Gene therapy clinical trials worldwide to 2007--an update." The journal of gene medicine 9.10 (2007): 833-42.
description	4.	BURNS, J C C. "VESICULAR STOMATITIS-VIRUS G GLYCOPROTEIN PSEUDOTYPED RETROVIRAL VECTORS - CONCENTRATION TO VERY HIGH-TITER AND EFFICIENT GENE-TRANSFER INTO MAMMALIAN AND NONMAMMALIAN CELLS." Proceedings of the National Academy of Sciences of the United States of America 90.17 (1993): 8033-8037.
description	5.	Sorrell, David A A. "Targeted modification of mammalian genomes." Biotechnology advances 23.7-8 (2005): 431-69.
description	6.	Wirth, T. "History of gene therapy." Gene 525.2 (2013): 162-169.
description	7.	Edelstein, Michael L L. "Gene therapy clinical trials worldwide 1989-2004 - an overview." The journal of gene medicine 6.6 (2004): 597-602.
description	8.	Asokan, R Jude J. "Adeno-associated virus serotypes: vector toolkit for human gene therapy." Molecular therapy 14.3 (2006): 316-27.
description	9.	Verma, Inder M. "Gene therapy: twenty-first century medicine." Annual review of biochemistry 74.1 (2005): 711-38.
description	10.	Stitz, J. "Lentiviral vectors pseudotyped with envelope glycoproteins derived from gibbon ape leukemia virus and murine leukemia virus 10A1." Virology 273.1 (2000): 16-20.
description	11.	Calvo, M. "Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 Disease." Science 288.5466 (2000): 669-672.
description	12.	Grunweller Arnold, A.. "Comparison of different antisense strategies in mammalian cells using locked nucleic acids, 2'-O-methyl RNA, phosphorothioates and small interfering RNA." Nucleic Acids Research 31.12 (2003): 3185-3193.
description	13.	Snow, A A. "Genetically engineered organisms and the environment: Current status and recommendations." Ecological applications 15.2 (2005): 377-404.
description	14.	Herzog, Roland W W. "Treatment of human disease by adeno-associated viral gene transfer." Human genetics 119.6 (2006): 571-603.
description	15.	Bergman, R. "A Unique Pattern of Dyskeratosis Characterizes Epidermolytic Hyperkeratosis and Epidermolytic Palmoplantar Keratoderma." The American journal of dermatopathology 30.2 (2008): 101-105.
description	16.	Greenwald, Richard B. "Effective drug delivery by PEGylated drug conjugates." Advanced Drug Delivery Reviews 55.2 (2003): 217-250.
description	17.	Huang, L. "Gene therapy progress and prospects: non-viral gene therapy by systemic delivery." Gene therapy 13.18: 1313-287.
description	18.	Lund, A. "Transcriptional silencing of retroviral vectors." Journal of biomedical science 3.6 (1996): 365-378.
description	19.	Talbot, N. "The pursuit of ES cell lines of domesticated ungulates." Stem Cell Reviews 4.3 (2008): 235-254.
description	20.	MacKenzie, T. "Efficient transduction of liver and muscle after in utero injection of lentiviral vectors with different pseudotypes." Molecular therapy 6.3 (2002): 349-358.